CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 114 enrolled
Drug / intervention
Fortified Beverage Powder +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03155269
NCT03155269N/ACompleted

Impact of a Nutritional Supplement on Bone Turnover Markers in Indian Healthy Premenopausal Women (25-45 Yrs; Inclusive) After 6 Months of Intervention: a Randomised Double Blind Controlled Trial

GlaxoSmithKline·interventional·Posted May 16, 2017·Updated Apr 12, 2019

In Brief

A clinical study evaluating Fortified Beverage Powder and Non fortified beverage Powder for Growth and Development. Completed, enrolled 114 participants across 1 site.

Detailed Summary

To investigate the effect of nutritional supplement on bone turnover markers (which are sensitive and respond quickly to nutrition or drug intervention) in Indian healthy premenopausal women after 6 months of intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIndia
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 16, 2017
Enrollment StartMay 25, 2017
Primary CompletionJan 16, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.1 years ago

Interventions

Fortified Beverage Powderdietary

The tumbler will be filled with water up to the 200 mL mark. The entire contents of one sachet (Fortified beverage powder) will be gradually emptied in the tumbler with intermittent stirring to avoid formation of lumps. The reconstituted product will be consumed by the participants immediately orally.

Non fortified beverage Powderdietary

The tumbler will be filled with water up to the 200 mL mark. The entire contents of one sachet (Non fortified beverage powder) will be gradually emptied in the tumbler with intermittent stirring to avoid formation of lumps. The reconstituted product will be consumed by the participants immediately orally.